Haemonetics | HAE - Betriebsaufwand





Betriebsaufwand Veränderung Datum
Avanos Medical USD 782.1M 625.97M 2026-03
Baxter International USD 6.04B 2.85B 2026-03
Becton, Dickinson and Co. USD 24.13B 19.54B 2026-03
Boston Scientific USD 4.15B 107M 2026-03
Cerus USD 34.78M 2.98M 2024-12
Cooper Companies USD 1.11B 301.2M 2026-03
Fresenius EUR 5.25B 337M 2025-12
Fresenius Medical Care EUR 4.34B 63M 2026-03
Globus Medical USD 595.85M 49.26M 2026-03
Haemonetics USD 134.99M 1.26M 2025-12
ICU Medical USD 514.62M 4.48M 2025-12
Intuitive Surgical USD 1.91B 89.8M 2026-03
Medtronic USD 7.72B 436M 2026-03
Merit Medical Systems USD 337.72M 2.02M 2026-03
Neogen USD 214.5M 15.57M 2025-12
OraSure Technologies USD 40.35M 2.45M 2025-12
Plus Therapeutics USD 7.11M 1.23M 2025-12
Quidel USD 1.85B 1.09B 2026-03
ResMed USD 925.74M 525K 2026-03
STAAR Surgical USD 76.12M 7.38M 2026-03
Steris USD 1.27B 51.5M 2026-03
Stryker USD 4.92B 284M 2026-03
Teleflex USD 3.08B 2.55B 2026-03
Terumo JPY 268.87B 16.12B 2026-03
Thermo Fisher Scientific USD 9.09B 821M 2026-03
US Physical Therapy USD 185.87M 86K 2026-03
Zimmer Biomet Holdings USD 1.69B 249.3M 2026-03